Current position:Home >Product >
N-acetyl-L-alpha-aspartyl-D-alpha-glutamyl-L-isoleucyl-L-valyl-(4R)-4-(benzyloxy)-L-prolyl-L-norvalinamide
N-acetyl-L-alpha-aspartyl-D-alpha-glutamyl-L-isoleucyl-L-valyl-(4R)-4-(benzyloxy)-L-prolyl-L-norvalinamide(737001-70-6)
- Name: N-acetyl-L-alpha-aspartyl-D-alpha-glutamyl-L-isoleucyl-L-valyl-(4R)-4-(benzyloxy)-L-prolyl-L-norvalinamide
- Synonyms:
- Molecular Formula:C39H59N7O12
- Molecular Weight:817.9255
- CAS Registry Number:737001-70-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 68239-27-0/3-Chloro-4-(morpholin-4-yl)-3-cyclobutene-1,2-dione
- 84559-98-8/3-(methylthio)propyl isovalerate
- 1891-24-3/1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol
- 33421-53-3/2,3-DIPHENYLPYRIDINE
- 5726-77-2/3-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1-[3-[[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]carbamoylamino]propyl]urea
- 3644-56-2/2-CHLORO-N-(2,6-DICHLOROPHENYL)ACETAMIDE
- 30034-57-2/6-bromo-4-nitro-1,3-benzodioxole-5-carbaldehyde
- 52965-57-8/7,8-dioxabicyclo[4.2.2]decane
- 75479-32-2/4-methyl-N-(2-{[(E)-phenylmethylidene]amino}phenyl)benzenesulfonamide
- 6231-49-8/N-benzyl-4-bromo-N-[2-(morpholin-4-yl)-2-oxoethyl]benzenesulfonamide
- 57872-66-9/â-D-Mannopyranoside,O-[(1R)-4-C-[(1S)-1- methoxyethyl]-2,3-O-methylene-Larabinopyranosylidene]-( 1f3-4)-2-O-methyl- R-L-lyxopyranosyl O-6-deoxy-3-C-methyl-â-Dmannopyranosyl-( 1f3)-O-6-deoxy-4-Omethyl- â-D-galactopyranosyl-(1f4)-2,6-di- O-methyl-
- 50719-83-0/Pyrindicine
- 112279-11-5/tenebrosin A
- 91844-68-7/1,4-Benzenediamine, N,N-diphenyl-, reaction products with styreneand 2,4,4-trimethylpentene
- 104100-25-6/4-Morpholineethanol, 2-hydroxy-2-(p-(isobutylsulfonyl)phenyl)-, hydroc hloride, hydrate
- 92245-34-6/2-(benzylsulfanyl)-1-(prop-2-en-1-yl)pyrimidin-4(1H)-one
- 53103-13-2/4-chloro-2-(4-chlorobenzoyl)benzoic acid
- 81741-73-3/1,2-Digermanediamine, N,N,N,N,1,1,2,2-octaethyl-
- 4471-37-8/Anthra[2,1,9-mna]naphth[2,3-h]acridin-5(16H)-one,10,15-bis(sulfooxy)-, sodium salt (1:2)
- 737001-70-6/N-acetyl-L-alpha-aspartyl-D-alpha-glutamyl-L-isoleucyl-L-valyl-(4R)-4-(benzyloxy)-L-prolyl-L-norvalinamide
- 35732-96-8/1H-Benz[e]indene,3-[(1R)-1,5-dimethylhexyl]- dodecahydro-3a,6,9b-trimethyl-7-(1-methylethyl)- 6-propyl-,(3R,3aR,5aS,6S,7S,9aR,- 9bS)-
- 28343-71-7/Acetic acid,[(1R,4aS,4bR,8aS,10aS)-dodecahydro-1,4b,8,8-tetramethyl-2(1H)-phenanthrenylidene]-,(2Z)- (9CI)
- 97926-44-8/Fatty acids, C18 and C18-unsatd., branched and linear
- 106762-91-8/(1R,2R,4S)-2-(5,7-diamino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-4-(hydroxymethyl)cyclopentanol
- 66317-00-8/4-Thiazolidinecarboxylic acid,5,5-dimethyl-2-[2-oxo-1-[(phenylacetyl) amino]-2-[(phenylmethyl)amino]ethyl]-,[2R-[2R(R*),4â]]-
- 56348-77-7/2-bromo-4-chloro-8-fluorophenoxathiine
- 68239-45-2/Cuprate(4-), (mu-((6,6-((3,3-di(hydroxy-kappaO)(1,1-biphenyl)-4,4-diyl)bis((azo-kappaN1)(4,5-dihydro-3-methyl-5-(oxo-kappaO)-1H-pyrazole-4,1-diyl)))bis(1,3-naphthalenedisulfonato))(8-)))di-, tetrahydrogen
- 9014-44-2/toxohormone
- 2294-90-8/2,4-diphenylbut-3-enoic acid
- 157291-77-5/b-D-Glucopyranoside,2-[[[[2-[(2-cyclopenten-1-ylcarbonyl)oxy]-1,3-dihydroxy-6-oxocyclohexyl]carbonyl]oxy]methyl]-4-hydroxyphenyl,2,6-di-2-cyclopentene-1-carboxylate (9CI)